Navigation Links
Real Time Genomics to Show SLIM Search(TM) Technology on Windows HPC Server 2008 at Bio-IT World Conference
Date:4/27/2009

Introducing Deep Genomic Analysis

SAN FRANCISCO, April 27 /PRNewswire/ -- Real Time Genomics will demonstrate solutions for deep genomic analysis at Bio-IT World Conference 2009 in Boston, April 27-29. Two applications, one for comparative genomics and another for gene expression, show genome-scale computation in real time using a compute cluster on Windows HPC Server 2008. The demonstration can be seen at kiosk #3 in Microsoft's exhibit space, booth #311.

SLIM Search sequence comparison technology from Real Time Genomics offers genomic mapping and alignment functions that are highly tolerant of mismatches such as indels and substitutions. This makes SLIM Search well suited to challenging problems such as SNP discovery during disease investigation, where millions of reads must be accurately mapped against the full human genome.

Working with Microsoft, Real Time Genomics has optimized its code to operate with the Windows HPC Server 2008 platform. "Real Time Genomics helps give genomic researchers the ability to perform deep genomic analysis, in real time, while also benefiting from Microsoft's easy-to-deploy, easy-to-use and widely supported platform," said Michael Naimoli, U.S. life sciences industry solutions director, Microsoft Corp.

High growth expectations for the next generation sequencing systems market may be tempered by the realization that current analysis tools are challenged to unlock value from the data. "The next generation of sequencing systems has turned the tables making sequencing data a commodity and elevating its analysis to the highest level," said Dr. Hugh Young Rienhoff, Jr., Founder, MyDaughtersDNA.org. "Whoever builds the interpretive platform for this massive data load will take the prize."

About Real Time Genomics

Real Time Genomics, Inc. (http://www.realtimegenomics.com) offers solutions for deep genomic analysis to researchers using next generation DNA sequencing technologies. The company is building genomics applications based on its own fast, accurate and mismatch tolerant read mapping and alignment algorithm. Real Time Genomics is a private, San Francisco based company backed by investment from Catamount Ventures.


'/>"/>
SOURCE Real Time Genomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Science Magazine to Host Webinar on Advances in Cancer Genomics
2. Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics"
3. Monsantos Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
4. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
5. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
6. Sirius Genomics to Present at Invest Northwest Conference
7. Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology Annual Meeting
8. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
9. Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
10. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
11. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can ... adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect ... SalivaLab , the relationship between insulin and other relevant biomarkers can be extensively ...
(Date:2/23/2017)... and SAN FRANCISCO , Feb. 23, ... medicine company, and Beyond Type 1, a not-for-profit advocacy ... diabetes, today announced a grant from Beyond Type 1 ... for type 1 and other insulin-requiring diabetes.  ... developing innovative stem cell-derived cell replacement therapies with a ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , a leader in Atomic ... all SPIE attendees and Park customers on Feb. 27, 2017 from 12-2pm ... Jose Convention Center. The luncheon will feature a talk on Automated AFM for ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
Breaking Biology News(10 mins):